Skip to search formSkip to main contentSkip to account menu

ImuVert

A membrane vesicle/ribosome preparation derived from the bacterium Serratia marcescens with immunomodulatory activity. ImuVert triggers interferon… 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Antineoplastic AgentsBiological Products

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
PROTECTION AGAINST CYTOSINE ARABINOSIDE‐INDUCED ALOPECIA BY MINOXIDIL IN A RAT ANIMAL MODEL
Background. Alopecia is one of the most physically and psychologically distressing side effect of cancer chemotherapeutic agents… 
1993
1993
Clinical trial of Serratia marcescens extract and radiation therapy in patients with malignant astrocytoma.
PURPOSE A clinical trial was undertaken to determine the safety and efficacy of combining a biologic response modifier derived… 
1992
1992
Protection from chemotherapy-induced neutropenia by ImuVert.
Neutropenia is a major cause of chemotherapy-induced morbidity. This study examines the effect of ImuVert on the course of… 
1991
1991
Interleukin 1 protects from cytosine arabinoside‐induced alopecia in the rat model
Protection from cytosine arabinoside‐induced alopecia by ImuVert has recently been reported in a rat model. ImuVert, a biologic… 
1991
1991
Effect of prior cancer chemotherapy on human tumor-specific cytotoxicity in vitro in response to immunopotentiating biologic response modifiers.
Tumor-specific cytotoxicity was measured in fresh human biopsy specimens by a modification of the differential staining… 
1991
1991
Interleukin 1 protects against 1-beta-D-arabinofuranosylcytosine-induced alopecia in the newborn rat animal model.
Alopecia is one of the most psychologically distressing side effects of cancer chemotherapy. Previously, we made the following… 
1991
1991
Synergism of ara-C-imuvert combination in aborting the development of transplanted chloroleukemia in the rat.
The development of chloroleukemia in the rat after transplantation of C51 chloroma cells can be aborted by treatment with an… 
1990
1990
Treatment with Imuvert aborts development of chloroleukemia in newborn rats.
We have previously demonstrated that the successful transfer of rat chloroleukemia (Mia C51) cells to newborn rats is related to… 
1990
1990
Phase II trial of Serratia marcescens extract in recurrent malignant astrocytoma.
Nineteen assessable patients with recurrent malignant astrocytomas who had failed standard therapy (surgery, radiation, and/or… 
1989
1989
Augmentation of ADCC and cytotoxic T-cell activity with ImuVert.
We previously reported that natural killer cell activity of peripheral blood mononuclear cells (PBMC) from healthy human subjects… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)